{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:45Z","timestamp":1786649745037,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.4103\/0974-9233.80716","type":"journal-article","created":{"date-parts":[[2011,5,28]],"date-time":"2011-05-28T09:56:06Z","timestamp":1306576566000},"page":"196-197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity"],"prefix":"10.4103","volume":"18","author":[{"given":"Seemant","family":"Raizada","sequence":"first","affiliation":[{"name":"Al Bahar Eye Centre, Ibn Sina Hospital, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Al Kandari","sequence":"additional","affiliation":[{"name":"Al Bahar Eye Centre, Ibn Sina Hospital, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Al Foudari","sequence":"additional","affiliation":[{"name":"Al Bahar Eye Centre, Ibn Sina Hospital, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/0974-9233.65500","article-title":"Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity","volume":"17","author":"Ahmed","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0301-4738.62644","article-title":"Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factors","volume":"58","author":"Wani","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: A pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"}],"container-title":["Middle East African Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01436644-201118020-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:54Z","timestamp":1786647474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01436644-201118020-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4103\/0974-9233.80716","relation":{},"ISSN":["0974-9233","0975-1599"],"issn-type":[{"value":"0974-9233","type":"print"},{"value":"0975-1599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}